Insider · CIK 0001519672
Graf James A
cfoofficerowner
Files at NKGN (NKGen Biotech, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | NKGN NKGen Biotech, Inc. | JOther Common Stock | -63,634 | $0.00 | $0 | 2,082,507 | Dec 26, 2024 |
| Dec 20, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Private Placement Warrantsderivative | -757,942 | - | - | 1,145,831 | Dec 26, 2024 |
| Dec 20, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Working Capital Warrantsderivative | -93,334 | - | - | 96,472 | Dec 26, 2024 |
| Dec 2, 2024 | NKGN NKGen Biotech, Inc. | JOther Common Stock | -97,232 | $0.00 | $0 | 2,339,512 | Dec 23, 2024 |
| Dec 16, 2024 | NKGN NKGen Biotech, Inc. | JOther Common Stock | -83,214 | $0.00 | $0 | 2,256,298 | Dec 23, 2024 |
| Dec 18, 2024 | NKGN NKGen Biotech, Inc. | JOther Common Stock | -110,157 | $0.00 | $0 | 2,146,141 | Dec 23, 2024 |
| Dec 2, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Private Placement Warrantsderivative | -713,357 | - | - | 4,008,176 | Dec 23, 2024 |
| Dec 16, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Private Placement Warrantsderivative | -1,212,707 | - | - | 2,795,469 | Dec 23, 2024 |
| Dec 16, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Working Capital Warrantsderivative | -66,667 | - | - | 456,473 | Dec 23, 2024 |
| Dec 18, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Private Placement Warrantsderivative | -891,696 | - | - | 1,903,773 | Dec 23, 2024 |
| Dec 18, 2024 | NKGN NKGen Biotech, Inc. | DDisposition to issuer Working Capital Warrantsderivative | -266,667 | - | - | 189,806 | Dec 23, 2024 |
| Dec 6, 2024 | NKGN NKGen Biotech, Inc. | AGrant or award Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.